Insider Trading & Ownership - Powell David Jonathan

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Powell David Jonathan
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-11-27
Sale
2020-12-01
7:45 pm
Summit Therapeutics Inc.SMMTPowell David Jonathan
Chief Scientific Officer
43,282$4.4058$190,6941,213,298
(Direct)
View
2020-11-23
Sale
2020-11-25
7:51 pm
Summit Therapeutics Inc.SMMTPowell David Jonathan
Chief Scientific Officer
30,431$4.2973$130,7701,338,279
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-11-27
Exercise
2020-12-01
7:45 pm
N/A
2029-03-29
Summit Therapeutics Inc.SMMTPowell David Jonathan
Chief Scientific Officer
26,666$1.791,213,298
(Direct)
View
2020-11-27
Exercise
2020-12-01
7:45 pm
N/A
N/A
Summit Therapeutics Inc.SMMTPowell David Jonathan
Chief Scientific Officer
26,666$1.791,213,298
(Direct)
View
2020-11-27
Exercise
2020-12-01
7:45 pm
N/A
2028-10-19
Summit Therapeutics Inc.SMMTPowell David Jonathan
Chief Scientific Officer
16,616$1.921,213,298
(Direct)
View
2020-11-27
Exercise
2020-12-01
7:45 pm
N/A
N/A
Summit Therapeutics Inc.SMMTPowell David Jonathan
Chief Scientific Officer
16,616$1.921,213,298
(Direct)
View
2020-11-23
Exercise
2020-11-25
7:51 pm
N/A
2028-10-19
Summit Therapeutics Inc.SMMTPowell David Jonathan
Chief Scientific Officer
30,431$1.921,338,279
(Direct)
View
2020-11-23
Exercise
2020-11-25
7:51 pm
N/A
N/A
Summit Therapeutics Inc.SMMTPowell David Jonathan
Chief Scientific Officer
30,431$1.921,338,279
(Direct)
View

Ownership
2020-09-18
4:14 pm
N/A
2028-10-19
Summit Therapeutics Inc.SMMTPowell David Jonathan
Chief Scientific Officer
0$0464,686
(Direct)
View